Home Newsfeeds Stifel Maintains Buy on Sonendo, Lowers Price Target to $3

Stifel Maintains Buy on Sonendo, Lowers Price Target to $3

Stifel analyst Jonathan Block maintains Sonendo (NYSE:SONX) with a Buy and lowers the price target from $4 to $3.

byBenzinga Newsdesk

October 4, 2022

1 minute read

Stifel analyst Jonathan Block maintains Sonendo (NYSE:SONX) with a Buy and lowers the price target from $4 to $3.

YouTube Bids Adieu To This Feature Amid Focus Shift To Shorts, Community Posts

By Aveek Bhowmik

May 26, 5:54 AM

Alphabet Inc.‘s (NASDAQ:GOOG) (NASDAQ:GOOGL) online video-sharing platform, YouTube announced its decision to bid adieu to the Stories feature…

GOOG

Citigroup Maintains Neutral on Marathon Oil, Lowers Price Target to $30

By Benzinga Newsdesk

January 13, 10:58 AM

Citigroup analyst Scott Gruber maintains Marathon Oil (NYSE:MRO) with a Neutral and lowers the price target from $31 to $30.

MRO

Morgan Stanley Maintains Equal-Weight on Westinghouse Air Brake, Lowers Price Target to $84

By Benzinga Newsdesk

July 18, 10:21 AM

Morgan Stanley analyst Courtney Yakavonis maintains Westinghouse Air Brake (NYSE:WAB) with a Equal-Weight and lowers the price target from $94 to $84.

WAB

Medigus’ Polyrizon Inks Agreement To Develop Therapies For Traumatic Spinal Cord Injuries

By Vandana Singh

July 18, 8:51 AM

Polyrizon Ltd, in which Medigus Ltd (NASDAQ:MDGS) owns a 37.03% stake, signed a binding Collaboration Agreement with NurExone Biologic Inc for therapies for traumatic spinal…

MDGS

Stifel Maintains Buy on Sonendo, Lowers Price Target to $3

Related Posts

YouTube Bids Adieu To This Feature Amid Focus Shift To Shorts, Community Posts

Citigroup Maintains Neutral on Marathon Oil, Lowers Price Target to $30

Morgan Stanley Maintains Equal-Weight on Westinghouse Air Brake, Lowers Price Target to $84

Medigus’ Polyrizon Inks Agreement To Develop Therapies For Traumatic Spinal Cord Injuries